These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 36551782)

  • 21. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-motor and motor features in LRRK2 transgenic mice.
    Bichler Z; Lim HC; Zeng L; Tan EK
    PLoS One; 2013; 8(7):e70249. PubMed ID: 23936174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Synuclein- and MPTP-generated rodent models of Parkinson's disease and the study of extracellular striatal dopamine dynamics: a microdialysis approach.
    Bazzu G; Calia G; Puggioni G; Spissu Y; Rocchitta G; Debetto P; Grigoletto J; Zusso M; Migheli R; Serra PA; Desole MS; Miele E
    CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):482-90. PubMed ID: 20522009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson's Disease.
    Parrella E; Del Gallo F; Porrini V; Gussago C; Benarese M; Fabene PF; Pizzi M
    Front Behav Neurosci; 2022; 16():831664. PubMed ID: 35368305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathogenic LRRK2 R1441C mutation induces specific deficits modeling the prodromal phase of Parkinson's disease in the mouse.
    Giesert F; Glasl L; Zimprich A; Ernst L; Piccoli G; Stautner C; Zerle J; Hölter SM; Vogt Weisenhorn DM; Wurst W
    Neurobiol Dis; 2017 Sep; 105():179-193. PubMed ID: 28576705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probiotics Treatment Improves Hippocampal Dependent Cognition in a Rodent Model of Parkinson's Disease.
    Xie C; Prasad AA
    Microorganisms; 2020 Oct; 8(11):. PubMed ID: 33120961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal expression of familial Parkinson's disease A53T α-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice.
    Rothman SM; Griffioen KJ; Vranis N; Ladenheim B; Cong WN; Cadet JL; Haran J; Martin B; Mattson MP
    J Parkinsons Dis; 2013; 3(2):215-29. PubMed ID: 23938351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular autonomic dysfunction in animal models of Parkinson's disease.
    Fleming SM
    J Parkinsons Dis; 2011; 1(4):321-7. PubMed ID: 23933655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of prodromal Parkinson's disease in young adult
    Lechner SA; Welsch JM; Pahapill NK; Kaldenberg TAR; Regenbaum A; Kelm-Nelson CA
    Front Behav Neurosci; 2022; 16():867958. PubMed ID: 36172466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.
    Niu Y; Guo X; Chen Y; Wang CE; Gao J; Yang W; Kang Y; Si W; Wang H; Yang SH; Li S; Ji W; Li XJ
    Hum Mol Genet; 2015 Apr; 24(8):2308-17. PubMed ID: 25552648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease.
    Duty S; Jenner P
    Br J Pharmacol; 2011 Oct; 164(4):1357-91. PubMed ID: 21486284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurotoxin-Induced Rodent Models of Parkinson's Disease: Benefits and Drawbacks.
    El-Gamal M; Salama M; Collins-Praino LE; Baetu I; Fathalla AM; Soliman AM; Mohamed W; Moustafa AA
    Neurotox Res; 2021 Jun; 39(3):897-923. PubMed ID: 33765237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Methyl-4-phenyl-1,2,3,6 tetrahydropyridine/probenecid impairs intestinal motility and olfaction in the early stages of Parkinson's disease in mice.
    Choi JG; Huh E; Ju IG; Kim N; Yun J; Oh MS
    J Neurol Sci; 2018 Sep; 392():77-82. PubMed ID: 30031172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.
    Postuma RB; Aarsland D; Barone P; Burn DJ; Hawkes CH; Oertel W; Ziemssen T
    Mov Disord; 2012 Apr; 27(5):617-26. PubMed ID: 22508280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.
    Choudhury GR; Daadi MM
    PLoS One; 2018; 13(8):e0202770. PubMed ID: 30138454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
    Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
    Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognition in prodromal Parkinson's disease.
    Liepelt-Scarfone I; Ophey A; Kalbe E
    Prog Brain Res; 2022; 269(1):93-111. PubMed ID: 35248208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.
    Fereshtehnejad SM; Yao C; Pelletier A; Montplaisir JY; Gagnon JF; Postuma RB
    Brain; 2019 Jul; 142(7):2051-2067. PubMed ID: 31111143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.